Tower Research Capital LLC (Trc) Puma Biotechnology, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,786 shares of PBYI stock, worth $9,162. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,786

Previous 35 10717.14%

Holding current value

$9,162

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.25 - $4.03 $8,439 - $15,116	3,751 Added 10717.14%	3,786 $9,000
Q2 2024 Aug 13, 2024	SELL	$2.92 - $5.83 $4,838 - $9,660	-1,657 Reduced 97.93%	35 $0
Q1 2024 May 15, 2024	SELL	$4.29 - $7.4 $4,761 - $8,214	-1,110 Reduced 39.61%	1,692 $8,000
Q4 2023 Feb 13, 2024	SELL	$2.23 - $4.49 $3,632 - $7,314	-1,629 Reduced 36.76%	2,802 $12,000
Q3 2023 Nov 14, 2023	BUY	$2.63 - $4.09 $11,561 - $17,979	4,396 Added 12560.0%	4,431 $11,000
Q2 2023 Aug 14, 2023	SELL	$2.6 - $3.58 $12,526 - $17,248	-4,818 Reduced 99.28%	35 $0
Q1 2023 May 09, 2023	SELL	$2.21 - $4.82 $21,872 - $47,703	-9,897 Reduced 67.1%	4,853 $15,000
Q4 2022 Feb 10, 2023	SELL	$2.12 - $5.08 $9,773 - $23,418	-4,610 Reduced 23.81%	14,750 $63,000
Q3 2022 Nov 10, 2022	BUY	$2.27 - $3.84 $3,239 - $5,479	1,427 Added 7.96%	19,360 $46,000
Q2 2022 Aug 15, 2022	BUY	$1.64 - $3.3 $17,610 - $35,435	10,738 Added 149.24%	17,933 $52,000
Q1 2022 May 12, 2022	SELL	$2.13 - $3.24 $2,969 - $4,516	-1,394 Reduced 16.23%	7,195 $20,000
Q4 2021 Feb 14, 2022	BUY	$2.85 - $6.58 $11,511 - $26,576	4,039 Added 88.77%	8,589 $26,000
Q3 2021 Nov 15, 2021	BUY	$6.63 - $9.39 $1,067 - $1,511	161 Added 3.67%	4,550 $32,000
Q2 2021 Aug 16, 2021	SELL	$8.98 - $11.6 $13,730 - $17,736	-1,529 Reduced 25.84%	4,389 $41,000
Q1 2021 May 17, 2021	SELL	$9.38 - $13.63 $46,543 - $67,632	-4,962 Reduced 45.61%	5,918 $58,000
Q4 2020 Feb 16, 2021	BUY	$7.78 - $12.13 $54,926 - $85,637	7,060 Added 184.82%	10,880 $111,000
Q3 2020 Nov 16, 2020	SELL	$9.5 - $11.14 $1,178 - $1,381	-124 Reduced 3.14%	3,820 $38,000
Q2 2020 Aug 13, 2020	BUY	$7.01 - $13.24 $27,647 - $52,218	3,944 New	3,944 $41,000
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $109,133 - $253,197	-17,378 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$6.5 - $10.73 $99,612 - $164,437	15,325 Added 746.47%	17,378 $152,000
Q3 2019 Nov 05, 2019	BUY	$8.75 - $12.85 $17,963 - $26,381	2,053 New	2,053 $22,000
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $22,719 - $52,864	-1,132 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$41.2 - $59.85 $40,746 - $59,191	989 Added 691.61%	1,132 $52,000
Q2 2018 Aug 15, 2018	SELL	$48.3 - $68.25 $31,684 - $44,772	-656 Reduced 82.1%	143 $8,000
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $39,461 - $65,604	661 Added 478.99%	799 $54,000
Q4 2017 Feb 09, 2018	SELL	$93.85 - $132.45 $100,701 - $142,118	-1,073 Reduced 88.6%	138 $14,000
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $87,192 - $145,017	1,211	1,211 $145,000

Others Institutions Holding PBYI

# of Institutions

100

Shares Held

29M

Call Options Held

50.6K

Put Options Held

16.3K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $110M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Puma Biotechnology, Inc. Transaction History